PMID- 33312857 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201216 IS - 2213-0071 (Print) IS - 2213-0071 (Electronic) IS - 2213-0071 (Linking) VI - 31 DP - 2020 TI - Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex. PG - 101310 LID - 10.1016/j.rmcr.2020.101310 [doi] LID - 101310 AB - Multifocal micronodular pneumocyte hyperplasia (MMPH) is a benign proliferation of alveolar type II cells presenting as multiple pulmonary nodules at chest imaging, which is frequently seen in patients with tuberous sclerosis complex (TSC). We report a case of a woman with TSC and MMPH who received everolimus, a mechanistic target of rapamycin (mTOR) inhibitor, for the treatment of a subependymal giant cell astrocytoma (SEGA). After 3 months of therapy, a remarkable decrease in density of all pulmonary MMPH lesions was observed, without any change in size. This shows that everolimus is active on MMPH similarly to its effects on SEGA, renal angiomyolipomas, and pulmonary lymphangioleiomyomatosis in TSC, and suggests that the dysregulated activation of mTOR which characterizes TSC also plays a role in the pathogenesis of MMPH. CI - (c) 2020 The Authors. FAU - Daccord, Cecile AU - Daccord C AD - Department of Respiratory Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Nicolas, Aymeric AU - Nicolas A AD - Department of Radiodiagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Demicheli, Rita AU - Demicheli R AD - Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Chehade, Hassib AU - Chehade H AD - Department Woman-Mother-Child, Division of Paediatrics, Paediatric Nephrology Unit, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Hottinger, Andreas F AU - Hottinger AF AD - Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. AD - Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Beigelman, Catherine AU - Beigelman C AD - Department of Radiodiagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. FAU - Lazor, Romain AU - Lazor R AD - Department of Respiratory Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland. LA - eng PT - Case Reports DEP - 20201125 PL - England TA - Respir Med Case Rep JT - Respiratory medicine case reports JID - 101604463 PMC - PMC7720070 OTO - NOTNLM OT - Alveolar epithelial cells OT - Everolimus OT - Lung OT - Mechanistic target of rapamycin OT - Multifocal micronodular pneumocyte hyperplasia OT - Tuberous sclerosis COIS- The authors have no conflicts of interest to declare related to this work. AN, RD and HC have nothing to disclose. CD reports non-financial support from Boehringer-Ingelheim and Roche, outside the submitted work. AFH reports grants from Novocure, personal fees from Karyopharm and BMS, outside the submitted work. CB reports personal fees from Boehringer-Ingelheim, AstraZeneca, and Gilead Sciences, outside the submitted work. RL reports personal fees and non-financial support from Boehringer-Ingelheim, non-financial support from Roche and Vifor, outside the submitted work. EDAT- 2020/12/15 06:00 MHDA- 2020/12/15 06:01 PMCR- 2020/11/25 CRDT- 2020/12/14 10:58 PHST- 2020/07/02 00:00 [received] PHST- 2020/11/22 00:00 [accepted] PHST- 2020/12/14 10:58 [entrez] PHST- 2020/12/15 06:00 [pubmed] PHST- 2020/12/15 06:01 [medline] PHST- 2020/11/25 00:00 [pmc-release] AID - S2213-0071(20)30524-4 [pii] AID - 101310 [pii] AID - 10.1016/j.rmcr.2020.101310 [doi] PST - epublish SO - Respir Med Case Rep. 2020 Nov 25;31:101310. doi: 10.1016/j.rmcr.2020.101310. eCollection 2020.